Abstract #0127

Detecting glycolytic metabolism in glioblastoma using a new 1H MRS and [6,6'-2H2]glucose infusion based approach

Laurie J Rich¹, Puneet Bagga¹, Gabor Mizsei¹, Mitchell D Schnall¹, John A Detre², Mohammad Haris³, and Ravinder Reddy¹

¹Radiology, University of Pennyslvania, Philadelphia, PA, United States, ²Neurology, University of Pennyslvania, Philadelphia, PA, United States, ³Research Branch, Qatar University, Doha, Qatar

A key hallmark of malignant tissues is a metabolic shift from oxidative phosphorylation to glycolytic metabolism, leading to increased lactate production. Probing the kinetics of lactate production in vivo may play a key role in studying disease mechanisms and developing biomarkers of treatment response. Here, we developed a new approach for studying glycolytic metabolism in glioblastoma by combining ¹H MRS with infusion of deuterated glucose. Infusion of [6,6'-²H₂]glucose leads to downstream deuterium labeling of lactate, resulting in a reduction in the 1.33 ppm lactate peak on ¹H MRS and making it is possible to monitor the metabolic turnover of lactate.

This abstract and the presentation materials are available to members only; a login is required.

Join Here